Putative ATP-binding domain-containing protein 3-like protein pseudogene (None established (ENSG00000269388 is an Ensembl gene identifier, not a standard abbreviation))

The putative ATP-binding domain-containing protein 3-like protein pseudogene (ENSG00000269388) is annotated as a pseudogene in the human genome. Pseudogenes are DNA sequences derived from ancestral protein-coding genes that have acquired disabling mutations, rendering them nonfunctional at the protein level[2][3]. Sometimes, pseudogenes retain regulatory roles at the RNA level, such as acting as competing endogenous RNAs (microRNA decoys) that may modulate the expression of related functional genes[1][3]. However, there is no evidence that this specific pseudogene (ENSG00000269388) is transcribed, has a regulatory RNA function, or produces any protein. No clinical, pharmaceutical, or biological data support a therapeutic or biomarker role. Its annotation as a "putative ... pseudogene" indicates an uncertain or computationally predicted origin, not a characterized or validated gene product. Key limitations: - Pseudogenes are not considered conventional molecular targets (like enzymes, receptors, transporters, etc.) in drug development. - "Putative" combined with "pseudogene" highlights uncertainty, and no standard abbreviation or alias is recognized. - No molecular function, disease association, or drug interaction is established for ENSG00000269388. - It is not a protein-coding gene nor an established target in any therapeutic or diagnostic context. In summary: ENSG00000269388 refers to a pseudogene that resembles an ATP-binding protein gene but is not functional as a protein nor as a recognized drug target. Its roles are, at best, hypothetical and align with generic pseudogene features rather than specific biological or therapeutic relevance[1][2][3][5].